Q2 2025 · 13F-HR
Eversept Partners, LPholdings as filed
Filed 2025-08-14 · accession 0001697013-25-000008
$1.09B
Reported value
68
Positions
2025-06-30
Period end
The Brief · Eversept Partners, LP · Q2 2025
AI · grounded in 13F
Eversept Partners, LP established a new position in NATERA INC NTRA valued at $134.5M. The fund also initiated new stakes in INVESCO QQQ TR QQQ for $95M and GSK PLC GSK for $86.1M. Other new additions include VERA THERAPEUTICS INC VERA and REVVITY INC RVTY.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $134.5M | 12.4% | 796,375 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $95.0M | 8.74% | 172,200 | PUT | SOLE |
| 37733W204 | GSK | GSK PLC | $86.1M | 7.92% | 2,242,388 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $56.1M | 5.16% | 2,383,055 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $49.4M | 4.54% | 510,330 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $42.2M | 3.88% | 1,298,514 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $38.3M | 3.52% | 99,983 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $38.1M | 3.50% | 4,065,355 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $34.6M | 3.18% | 839,284 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $26.6M | 2.45% | 1,902,539 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $23.3M | 2.14% | 588,900 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $21.6M | 1.99% | 398,726 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $21.3M | 1.96% | 164,473 | Common | SOLE |
| 203668108 | CYH | COMMUNITY HEALTH SYS INC NEW | $20.9M | 1.92% | 6,144,384 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $20.5M | 1.89% | 1,526,164 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $20.3M | 1.87% | 394,139 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $19.5M | 1.79% | 1,315,033 | Common | SOLE |
| 98888T107 | ZIMV | ZIMVIE INC | $19.4M | 1.79% | 2,079,380 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $18.9M | 1.74% | 60,736 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $18.9M | 1.74% | 198,584 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $17.6M | 1.62% | 1,052,881 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $17.1M | 1.57% | 838,736 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $17.1M | 1.57% | 59,366 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $16.3M | 1.50% | 155,868 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $15.4M | 1.41% | 97,604 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $15.3M | 1.41% | 277,316 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $11.9M | 1.09% | 1,197,189 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $11.8M | 1.09% | 232,175 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $10.8M | 1.00% | 1,207,638 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $10.8M | 0.99% | 1,170,311 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $10.7M | 0.98% | 43,620 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $10.3M | 0.95% | 7,320,174 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $10.0M | 0.92% | 169,643 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $9.4M | 0.86% | 64,587 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $7.5M | 0.69% | 414,430 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $7.4M | 0.68% | 18,962 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $7.0M | 0.64% | 13,254 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $6.9M | 0.63% | 130,924 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $6.1M | 0.56% | 20,600 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $5.5M | 0.51% | 13,685 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.1M | 0.47% | 392,739 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $4.6M | 0.43% | 23,449 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $4.5M | 0.41% | 358,828 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $3.3M | 0.30% | 31,496 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $3.2M | 0.29% | 325,479 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $3.0M | 0.27% | 115,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.8M | 0.26% | 1,986,072 | Common | SOLE |
| 023111404 | AMRN | AMARIN CORP PLC | $2.7M | 0.25% | 167,276 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $2.6M | 0.24% | 697,710 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $2.3M | 0.21% | 235,990 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $2.3M | 0.21% | 18,620 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $2.1M | 0.19% | 1,695,762 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.1M | 0.19% | 99,338 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.8M | 0.17% | 533,409 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $1.6M | 0.15% | 2,292,261 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $1.5M | 0.14% | 640,673 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $1.5M | 0.14% | 211,469 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.4M | 0.13% | 610,231 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.3M | 0.12% | 1,640,430 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $1.1M | 0.10% | 37,980 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $1.1M | 0.10% | 257,154 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.1M | 0.10% | 109,324 | Common | SOLE |
| 34965K107 | FTRE | FORTREA HLDGS INC | $1.1M | 0.10% | 219,384 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $825,560 | 0.08% | 240,688 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $629,216 | 0.06% | 48,364 | Common | SOLE |
| 28238P109 | EHTH | EHEALTH INC | $558,201 | 0.05% | 128,322 | Common | SOLE |
| 60783X104 | MODVQ | MODIVCARE INC | $312,000 | 0.03% | 100,000 | Common | SOLE |
| H00263105 | ACIU | AC IMMUNE SA | $204,527 | 0.02% | 100,752 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.